Skip to main content

Posts

Showing posts from June, 2011

Could simply listening to Mozart help people with epilepsy?

Listening to music composed by Mozart could help control seizures. The news from researchers add to the health benefits discovered in the past that listening to classical music might help people dealing with epilepsy. The findings that were presented last month at the European College of Neurpsychopharmacology; is a large study and based on reviews of literature that might inspire your doctor to suggest this simple intervention, combined with current treatment. Researchers, Dr. Glanluca Sesso and Dr. Frederico Sicca from the University of Pisa specifically looked at how Mozart's music affects epilepsy. Their review included 9 published studies out of 147; based on solid science and of good quality. Daily listening changes brain signals tooMozart's music also changed brain signals that are commonly seen in patients diagnosed with epilepsy,  in addition to lowering the number of seizures for people that listen to music daily. Tehe reduction varied between 31 and 66 percent. Dr. …

Potential E. coli treatment developed 10 years ago

E. coli treatment ignored, but developed a decade ago

Scientists from the University of Adelaide say they developed a possible treatment that could stop deadly E. coli in its tracks a decade ago that never went to clinical trial because of lack of interest from commercial sectors.
The scientists produced a probiotic that binds to E. coli and was shown to protect mice from the harmful effects of toxins produced by E. coli that is claiming lives in Europe.
E. coli can shut down the kidneys and attack blood vessels, leading to severe illness and death. Researchers Dr Adrienne Paton, Associate Professor Renato Morona and Professor James Paton infected mice with virulent strains of E. coli in 2000.
The researchers published their findings that the mice were completely protected from fatal doses of toxins that produce gastrointestinal disease in journal Nature Medicine, but no further studies were developed.
The researchers say if the probiotic had gotten the attention of investors, and proved …